Similar to 18-GA, the GJ inhibitor heptanol decreased the proliferation of multiple myeloma cells, which express high levels of Cx43 and demonstrate GJIC, suggesting a pro-proliferative, pro-tumorigenic role for Cx43 in these cells [45]. This evidence concerns the gene GJA1 and plasma cell myeloma.